Gene Query: PEX6

Dataset Description Geneva Score
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 40.8
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 28.43
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 25.45
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 24.66
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 23.99
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 23.99
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 22.15
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 21.92
Pharmacologic inhibition of STAT5 in AML 20.59
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 18.64
Genome wide expression change by RNF168 knocking down in NEC cells 18.44
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 17.95
Altering cancer transcriptomes using epigenomic inhibitors 16.9
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 16.9
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 15.28
Inhibition of TNBC metastasis by Gpx1 15.06
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 13.59
Gene expression profiling of papillary thyroid cancer from central and invasive regions 13.48
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 13.26
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 12.81
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 11.99
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 11.98
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 11.98
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 11.95
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 11.94
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 11.26
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 11.13
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 11.12
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 11.06
RNA-seq of tumor cells following angiopellosis extravasation 10.93
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 10.71
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 10.68
Polarized B -cell functions 10.0
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 9.91
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 9.9
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 9.84
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 9.78
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 9.69
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.43
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 9.4
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 9.38
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 9.26
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 9.21
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 9.15
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 9.14
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.1
LncRNA-GAS5 negative regulation of YAP-target genes expression 9.09
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 8.98
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 8.98
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 8.84
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 8.63
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 8.53
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 8.45
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 8.38
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 8.3
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 8.3
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 8.24
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  8.18
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 7.75
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 7.61
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 7.61
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 7.4
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.33
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.16
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.16
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 7.1
Evaluating pre-clinical models for studying NASH driven HCC. 7.07
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.03
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 7.01
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 7.0
Discovering human diabetes-risk gene function with genetics and physiological assays 6.88
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 6.85
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 6.85
RNA-seq of MCF10A cells and CAF 6.82
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.78
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 6.77
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 6.77
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 6.77
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 6.69
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.68
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.67
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 6.63
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.62
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 6.62
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.59
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 6.58
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.56
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 6.56
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 6.44
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.43
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 6.35
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 6.35
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.28
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 6.27
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 6.25
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.24
Survival of pancreatic cancer cells lacking KRAS function 6.23
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.14
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 6.09
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.09
The landscape of alternative splicing in aggressive prostate cancers 6.08
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 6.01
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 5.98
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.9
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.88
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 5.85
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.58
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.58
RNA-seq of cells with TET1 knockout 5.57
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 5.55
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.51
T47D RNA-seq and ChrRNA-seq data 5.51
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.47
Regulating Interleukin-2 activity with engineered receptor signaling clamps 5.42
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 5.4
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.32
Differential Gene Expression between MCF10A and MCF7 cells 5.26
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 5.26
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.22
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 5.21
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 5.2
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 5.2
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 5.17
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 5.17
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 5.16
The role of FAM46C in myeloma cells 5.15
The role of FAM46C in myeloma cells [sequencing] 5.15
RNA-seq analysis of uveal melanoma cells treated with FR900359 5.14
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 5.13
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 5.13
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.12
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 5.03
RNA-seq data from human lymphoma cell lines 5.03
ChIP-seq and RNA-seq from human lymphoma cell lines 5.03
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.02
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.01
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.01
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 4.95
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.9
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.88
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.81
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 4.81
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.72
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 4.72
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 4.72
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 4.62
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.6
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.59
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.59
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 4.58
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 4.58
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 4.58
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 4.58
Effect of mitochondria deficiency on senescence-associated gene expression 4.56
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 4.55
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 4.54
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.54
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.54
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 4.53
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.44
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.42
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 4.36
Accurate annotation of human protein-coding small open reading frames 4.35
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 4.34
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 4.31
Gene expressions of H9s in different culture systems 4.31
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.31
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 4.3
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.3
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.24
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.24
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 4.23
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 4.23
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 4.23
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.21
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.21
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.18
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 4.15
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 4.13
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.12
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 4.12
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 4.11
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.1
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 4.1
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 4.1
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.09
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.07
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.07
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.04
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.04
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.04
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.04
Identification of long noncoding RNAs regulated by p53 4.02
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.0
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.0
U1 snRNP telescripting regulates size-function stratified human genome 4.0
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 3.98
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.98
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 3.97
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 3.94
RNA-seq analysis of AML cells in response to ASLAN003 3.93
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.92
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 3.89
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 3.89
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.88
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 3.85
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 3.82
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 3.81
Transcriptome Profiling of Human Primary Monocytes 3.81
Gene expression changes after LOC550643 silencing 3.79
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.79
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.78
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 3.77
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 3.75
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.72
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.72
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 3.71
mRNA expression in human DAOY cells 3.69
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 3.68
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 3.68
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.65
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 3.64
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.63
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 3.63
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.58
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 3.5
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.45
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.45
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.45
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 3.43
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.4
Epigenome regulation during epidermal lineage commitment [RNA-seq] 3.37
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.37
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.37
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.37
Transcriptome of U251 cells overexpression complement component 7 3.37
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.36
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 3.34
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 3.34
Primary human trophoblast from term placenta 3.33
mRNA sequencing of oropharyngeal cancer cell lines 3.3
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.27
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.26
RNA-seq of naive and primed ES cells 3.23
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.21
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 3.17
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.15
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 3.12
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.09
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.08
ML29755 RNA-seq data 3.07
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 3.06
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.06
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 3.04
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 3.03
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.96
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 2.96
Clinker: visualizing fusion genes detected in RNA-seq data 2.94
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.9
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.86
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 2.86
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 2.86
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.82
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 2.79
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 2.76
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.76
FOXP2's impact on the primate transcriptome 2.74
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 2.72
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 2.71
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.68
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.67
RNA seq with AML (NB4) cells upon FTO inhibition 2.6
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.58
Targeting MTHFD2 in Acute Myeloid Leukemia 2.55
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.53
Tpl-2 small molecule project 2.51
Tpl-2 and MEK small molecule inhibitors 2.51
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.49
The role of m6A/m-RNA methylation in stress response regulation 2.49
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 2.49
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 2.48
CHD1 regulates cell fate determination by activation of differentiation-induced genes 2.45
MeRIP-seq for heat shock in B-cell lymphoma cells 2.45
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.44
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.42
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.42
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 2.36
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.33
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 2.32
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 2.29
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 2.28
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 2.27
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.25
Human ovarian granulosa cell transcriptome 2.22
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.17
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 2.15
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 2.14
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 2.13
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 2.12
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 2.11
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.1
Oncogenic roles of ARID5B in T-ALL 2.1
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.1
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.1
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.08
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.06
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.06
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 2.04
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 2.04
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.01
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 2.01
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.99
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 1.96
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 1.96
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.94
Ribosome profiling upon inhibition of eIF4A 1.94
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.93
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.93
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.93
The role of the Calcium-Sensing receptor in colorectal cancer 1.91
naive T cell heterogeneity after neonatal thymectomy 1.9
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.9
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.9
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.89
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.89
RNA-seq analysis of differentiating human erythroblasts 1.83
Transciptomic profiling of human fetal lung samples 1.8
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.8
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.78
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.78
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.77
Epigenome regulation during epidermal lineage commitment 1.77
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.74
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.72
Gene expression analysis in response to hypoxic pathway inhibition 1.68
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 1.67
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 1.67
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.63
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.63
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.6
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 1.59
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.59
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.58
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.55
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.55
RNA splicing alteration on glioblastoma and normal neural stem cells 1.54
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.54
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 1.51
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 1.49
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.45
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.45
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.44
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  1.44
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.42
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.37
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.32
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.31
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.31
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.3
RNA-sequencing of human liver tissue 1.29
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.28
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.27
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.27
Transcriptional effect of ETV1 knockdown in melanoma cells 1.27
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.24
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.16
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 1.16
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 1.16
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.1
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.09
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.09
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.08
BACH2 in human plasma cell fate decision 1.07
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 1.07
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.07
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.05
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.03
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.03
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.03
Hepatic transcriptome of pediatric hepatoblastoma. 1.01
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.99
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.97
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.97
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.96
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.95
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 0.95
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.94
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.93
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.93
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.92
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.92
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.92
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.89
Gene expression profile in breast cancer cell lines using RNA sequencing 0.89
Human islets of varying quality: the good, the (not so) bad and the ugly 0.88
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.88
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.87
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.87
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.86
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.86
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 0.86
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.84
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.81
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.81
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.79
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 0.78
Leucegene: ALL sequencing 0.78
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.78
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.78
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.77
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.76
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.76
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.76
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.75
CDK4/6 inhibitor resistance in prostate cancer 0.75
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.75
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.75
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 0.75
Modeling Human Cancer-induced Cachexia (Human) 0.7
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.7
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.69
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.69
Global epigenomic reconfiguration during mammalian brain development 0.68
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.68
U2AF1 mutations alter splice site recognition in hematological malignancies 0.67
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.67
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.66
quanTIseq: quantifying immune contexture of human tumors 0.66
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.66
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.61
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.58
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.53
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.53
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.51
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.5
SF3B1 Degron knockdown RNA-seq 0.49
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.49
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.49
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.48
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.48
Expression analysis of the TAF1 syndrome 0.48
Investigate A2M treatment on human prostate cancer xenograft in mice 0.46
Investigate A2M treatment on human prostate cancer and mouse liver 0.46
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.44
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.43
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.43
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.43
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.42
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.42
miRNAs affected by antagomiR-17 treatment 0.4
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.39
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.39
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.39
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.39
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.36
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.34
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.34
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.34
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.29
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.29
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.28
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.28
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.28
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.25
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.24
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.23
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.22
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.22
Gene expression analysis of breast cancer cell-lines 0.21
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.21
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.2
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.18
RNA sequencing of human pancreatic cancer cell lines 0.18
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.18
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.17
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 0.15
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 0.15
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.14
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.14
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.13
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.11
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.11
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.11
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.11
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.1
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.1
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.09
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.09
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.09
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.08
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.08
Function and hormonal regulation of GATA3 in human first trimester placentation 0.05
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.05
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.02
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.02
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.01
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.01
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation